Literature DB >> 20642050

[Abandonment of tuberculosis treatment among patients co-infected with TB/HIV].

Ivaneide Leal Ataide Rodrigues1, Larissa Lima Monteiro, Régia Hevelline Barros Pacheco, Sílvio Eder Dias da Silva.   

Abstract

This study aimed at analyzing the reasons that patients co-infected with tuberculosis and HIV leave the treatment of tuberculosis and to know the conduct of the health team toward that abandonment. The study, using a qualitative approach, performed semi-structured interviews on 45 professionals working at a referral health center in Pará state. Two units emerged based on the thematic analysis: patient-associated factors that make TB treatment adherence difficult; and service-associated factors that contribute to treatment abandonment. It was found that, in terms of the patients, that their low socioeconomic condition was the most common factor that led to abandonment. Other factors that led to this outcome included the adverse drug effects, the use of illegal drugs, and poor personal motivation. Regarding the service, issues related to the physical structure, working process organization and accessibility were also relevant to their non-adherence. Results show there is a need to change the practices performed at the health care services.

Entities:  

Mesh:

Year:  2010        PMID: 20642050     DOI: 10.1590/s0080-62342010000200020

Source DB:  PubMed          Journal:  Rev Esc Enferm USP        ISSN: 0080-6234            Impact factor:   1.086


  7 in total

1.  Profile and follow-up of patients with tuberculosis in a priority city in Brazil.

Authors:  Jisleny da Cruz Pereira; Marcio Roberto Silva; Ronaldo Rodrigues da Costa; Mark Drew Crosland Guimarães; Isabel Cristina Gonçalves Leite
Journal:  Rev Saude Publica       Date:  2015-02-27       Impact factor: 2.106

2.  Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study.

Authors:  Thiago Nascimento do Prado; Angélica Espinosa Miranda; Fernanda Mattos de Souza; Elias dos Santos Dias; Lorena Kellen Fernandes Sousa; Denise Arakaki-Sanchez; Mauro N Sanchez; Jonathan E Golub; Ethel Leonor Maciel
Journal:  BMC Infect Dis       Date:  2014-07-28       Impact factor: 3.090

Review 3.  Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs.

Authors:  Denise Rossato Silva; Marcela Muñoz-Torrico; Raquel Duarte; Tatiana Galvão; Eduardo Henrique Bonini; Flávio Ferlin Arbex; Marcos Abdo Arbex; Valéria Maria Augusto; Marcelo Fouad Rabahi; Fernanda Carvalho de Queiroz Mello
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

4.  [Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus coinfection in Peru, 2010-2015].

Authors:  Lisset García-Fernández; Carlos Benites; Byelca Huamán
Journal:  Rev Panam Salud Publica       Date:  2017-05-25

5.  Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.

Authors:  Felipe Lima Dos Santos; Ludmilla Leidianne Limirio Souza; Alexandre Tadashi Inomata Bruce; Juliane de Almeida Crispim; Luiz Henrique Arroyo; Antônio Carlos Vieira Ramos; Thaís Zamboni Berra; Yan Mathias Alves; Alessandro Rolim Scholze; Fernanda Bruzadelli Paulino da Costa; José Francisco Martoreli Júnior; Ana Carolina Scarpel Moncaio; Ione Carvalho Pinto; Ricardo Alexandre Arcêncio
Journal:  PLoS One       Date:  2021-04-09       Impact factor: 3.240

6.  Early identification of individuals at risk for loss to follow-up of tuberculosis treatment: A generalised hierarchical analysis.

Authors:  Shirley Verônica Melo Almeida Lima; Karina Conceição Gomes Machado de Araújo; Marco Antonio Prado Nunes; Carla Nunes
Journal:  Heliyon       Date:  2021-04-20

7.  Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008-2010.

Authors:  Ernesha Webb Mazinyo; Lindsay Kim; Sikhethiwe Masuku; Joey L Lancaster; Ronel Odendaal; Margot Uys; Laura Jean Podewils; Martie L Van der Walt
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.